Morning Briefing

"In an attempt to assess the impact of U.S. international assistance for AIDS, researchers from Stanford University carried out a review of the relationship between U.S. support provided through the President's Emergency Plan for AIDS Relief (PEPFAR) and adult mortality in PEPFAR focus countries in sub-Saharan Africa, and whether there were differences in outcome between these countries and other African countries which did not receive PEPFAR support," NAM's Aidsmap reports (Alcorn, 3/8). Presenting the results at the 19th Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle on Wednesday, Eran Bendavid said "[s]tatistical analysis found that adults living in focus countries between 2004 and 2008 had about a 20 percent lower odds of mortality compared to adults in non-focus countries," the Center for Global Health Policy's "Science Speaks" writes, adding, "Evidence for unintended health effects with respect to adult mortality is inconclusive, Bendavid said, but the likelihood of PEPFAR interventions eliciting unintended harms is low" (Mazzotta, 3/7).